June 29, 2018: Novartis (NVS) announced its intention to spinoff Alcon, its eye care division, into a separately-traded standalone company. The successful completion of the planned spinoff is subject to general market conditions, regulatory approvals, final Board of Directors endorsement and shareholder approval. In the event that all approvals are secured, the planned spinoff is expected to be completed in the first half of 2019.

November 13, 2018: Novartis (NVS) announced that Alcon has filed an initial Form 20-F registration statement with the US Securities and Exchange Commission (SEC) in relation to the previously-announced intention of Novartis to spin off its eye care division as an independent, publicly-traded company. An application will be made to list the shares in Alcon on the SIX Swiss Exchange (SIX) and the New York Stock Exchange (NYSE) under the ticker symbol "ALC".

January 30, 2019: Novartis International (NVS) announced that efforts toward the proposed 100-percent spinoff of the Alcon eye care division are progressing with the Novartis board of directors providing final endorsement of the potential transaction. Novartis shareholders will vote on the proposed spin-off at Novartis' annual general meeting of shareholders on February 28, 2019.

March 22, 2019: Novartis (NVS) confirmed that certain important conditions precedent for the 100% spin-off of the Alcon eye care business have been met, including receipt of certain necessary authorizations and rulings. Completion of the transaction, by way of a distribution of a dividend in kind to Novartis shareholders and ADR holders, is expected to be on April 9, 2019.

April 9, 2019: Novartis (NVS) completed the spin-off of the Alcon eye care devices business through a dividend-in-kind distribution to holders of Novartis shares and ADRs (American Depositary Receipts), with each holder receiving 1 Alcon share for every 5 Novartis shares or ADRs held on April 8, 2019, at the close of business. Shares in Alcon, Inc. will be listed and commence trading today under the symbol "ALC" on the SIX Swiss Exchange (SIX) from 09:00 CET and on the New York Stock Exchange (NYSE) from 09:30 EST.

May 1, 2018: Ironwood Pharmaceuticals (IRWD), a commercial biotech company, announced that its Board of Directors has authorized an intent to separate into two independent, publicly traded companies (Ironwood and “R&D Co.”). The separation is expected to be completed in the first half of 2019 and is anticipated to be tax-free to Ironwood shareholders.

January 24, 2019: Ironwood Pharmaceuticals (IRWD) announced the composition of the Ironwood and Cyclerion Therapeutics, Inc. boards of directors, in connection with the previously announced planned business separation which is on track to be completed in the first half of 2019.

April 1, 2019: Ironwood Pharmaceuticals (IRWD) announced that it has completed the tax-free spin-off of its soluble guanylate cyclase (sGC) business, Cyclerion Therapeutics, Inc. (CYCN).

December 11, 2015: DuPont (DD) and The Dow Chemical Company (DOW) announced that their boards of directors unanimously approved a definitive agreement under which the companies will combine in an all-stock merger of equals. The combined company will be named DowDuPont. The parties intend to subsequently pursue a separation of DowDuPont into three independent, publicly traded companies through tax-free spin-offs. This would occur as soon as feasible, which is expected to be 18-24 months following the closing of the merger, subject to regulatory and board approval.

August 4, 2017: DuPont (DD) and The Dow Chemical Company (DOW) announced that all required regulatory approvals and clearances have been received, that all conditions to closing of their merger of equals have been satisfied, and that their merger of equals will close after the market closes on August 31, 2017. Shares of Dow and DuPont will cease trading at the close of the New York Stock Exchange on August 31. Shares of DowDuPont will begin trading on the NYSE under the stock ticker symbol “DWDP” on September 1, 2017. The companies continue to expect the intended spin-offs to occur within 18 months of closing.

September 1, 2017: DowDuPont (DWDP) announced the successful completion of the merger of equals between The Dow Chemical Company and E.I. du Pont de Nemours & Company (“DuPont”), effective Aug. 31, 2017. The combined entity is operating as a holding company under the name “DowDuPont™” with three divisions – Agriculture, Materials Science and Specialty Products.

September 12, 2017: DowDuPont (DWDP) announced that its Board of Directors and management, with the assistance of independent advisors, have completed their comprehensive review of the portfolio composition of the three intended independent companies. Following the portfolio realignments, the three intended companies of DowDuPont are as follows:
1) A leading Agriculture Company
2) A leading Materials Science Company
3) A leading Specialty Products Company

On a forecasted 2017 basis, the businesses that will be realigned to the Specialty Products Division account for total net sales of more than $8 billion and operating EBITDA of approximately $2.4 billion, including approximately 40 percent of the heritage Dow Corning EBITDA. Relative to the original merger agreement, the adjustments are as follows:

- Approximately $4 billion of net sales from the heritage Dow portfolio, evenly split between the Consumer Solutions and Infrastructure Solutions segments; and

- Approximately $4 billion of net sales from the heritage DuPont Performance Polymers business moving to the Specialty Products Division.

October 26, 2017: DowDuPont (DWDP) filed a  Form 8-K reflecting the new segment structure of DowDuPont. Following the Merger, new reportable segments were created and DowDuPont began to manage and report its operating results through the new reportable segments: Agriculture; Performance Materials & Coatings; Industrial Intermediates & Infrastructure; Packaging & Specialty Plastics; Electronics & Imaging; Nutrition & Biosciences; Transportation & Advanced Polymers; Safety & Construction and Corporate. DowDuPont will report geographic information for the following areas: U.S. & Canada, Asia Pacific, Latin America and Europe, Middle East, and Africa ("EMEA"). As a result of the Merger, Dow changed the geographic alignment for the country of India to be reflected in Asia Pacific (previously reported in EMEA) and aligned Puerto Rico to U.S. & Canada (previously reported in Latin America).

February 26, 2018: DowDuPont (DWDP) unveiled the brand names it plans to give the three independent companies it will create following the merger of the former DuPont and Dow Chemical. The company said the agriculture division will be named Corteva Agriscience, the materials science division will be called Dow and the specialty products division will be called DuPont. The materials science division is expected to be spun off by the end of the first quarter of 2019, while agriculture and specialty products are expected to separate by June 1, 2019.

March 8, 2019: DowDuPont (DWDP) said its board has approved the separation of its materials science division, paving the way for the creation of the new Dow. Dow will be an independent, publicly traded company that will list on the New York Stock Exchange on or about March 20 under the ticker symbol "DOW WI" on a when-issued basis and then begin regular-way trading April 2 under the ticker symbol "DOW."

April 1, 2019: DowDuPont (DWDP) announced that it has completed the separation of its Materials Science Division through the spin-off of Dow Inc.. Dow will begin “regular way” trading on the NYSE under the symbol “DOW”.

December 14, 2017: The Walt Disney Company (DIS) and Twenty-First Century Fox (FOX) announced that they have entered into a definitive agreement for Disney to acquire 21st Century Fox, including the Twentieth Century Fox Film and Television studios, along with cable and international TV businesses, for approximately $52.4 billion in stock. Immediately prior to the acquisition, 21st Century Fox will separate the Fox Broadcasting network and stations, Fox News Channel, Fox Business Network, FS1, FS2 and Big Ten Network into a newly listed company that will be spun off to its shareholders.

March 19, 2019: Twenty-First Century Fox (TFCF) announced that it has completed the distribution of all issued and outstanding shares of Fox Corporation (FOXA) common stock to 21CF stockholders on a pro rata basis. 21CF and FOX are now each a standalone, publicly traded company.

August 2, 2017: FMC Corporation (FMC) announced in their Quarterly Report, filed on August 2, 2017 that they continue to invest in FMC Lithium and to move forward with their plans to expand their lithium hydroxide operations. They will continue to operate FMC Lithium as a standalone business within FMC. Their strategic intent is that they will spin off FMC Lithium as a separate, publicly traded company.

February 26, 2018: FMC Corp (FMC) is planning a $500 million initial public offering of a stake in its lithium business on the New York Stock Exchange this fall.

February 11, 2019: FMC Corporation (FMC) announced that its Board of Directors has approved the distribution of all of its remaining interest in Livent Corporation (LTHM) to FMC stockholders, payable on March 1, 2019, to shareholders of record as of 5:00 p.m. EST on February 25, 2019.

March 1, 2019: FMC Corporation (FMC) announced that it has completed the previously announced distribution of 123,000,000 shares of common stock of Livent Corporation (LTHM).

May 21, 2018: Wabtec Corporation (WAB) entered into a definitive agreement to combine with GE Transportation, a unit of General Electric Company (GE). GE Transportation will be combined in a transaction in which GE will (i) sell a portion of the assets of GE Transportation to Wabtec; (ii) complete the spin-off or split-off of a portion of GE Transportation to GE shareholders; and (iii) immediately thereafter merge GE Transportation with a wholly owned subsidiary of Wabtec. The transaction is expected to close in early 2019, subject to customary closing conditions, approval by Wabtec shareholders, and regulatory approvals.

January 25, 2019: Wabtec Corporation (WAB) and GE (GE) announced that they have modified the terms of their merger agreement. Under the terms of the modified arrangements, which have been approved by Wabtec’s Board and by the Finance and Capital Allocation Committee of the GE Board, GE will complete the spin off of a portion of GE Transportation to GE shareholders and immediately thereafter merge GE Transportation into a wholly owned subsidiary of Wabtec. Upon closing, Wabtec shareholders will own approximately 50.8% of Wabtec on a fully diluted basis, compared to approximately 49.9% under the previous terms.

February 4, 2019: General Electric (GE) said that it expects to close the merger of its transportation business with Wabtec Corp (WAB) on February 25 and set a record date for distribution of shares.

June 29, 2018: Novartis (NVS) announced its intention to spinoff Alcon, its eye care division, into a separately-traded standalone company. The successful completion of the planned spinoff is subject to general market conditions, regulatory approvals, final Board of Directors endorsement and shareholder approval. In the event that all approvals are secured, the planned spinoff is expected to be completed in the first half of 2019.

November 13, 2018: Novartis (NVS) announced that Alcon has filed an initial Form 20-F registration statement with the US Securities and Exchange Commission (SEC) in relation to the previously-announced intention of Novartis to spin off its eye care division as an independent, publicly-traded company. An application will be made to list the shares in Alcon on the SIX Swiss Exchange (SIX) and the New York Stock Exchange (NYSE) under the ticker symbol "ALC".

January 30, 2019: Novartis International (NVS) announced that efforts toward the proposed 100-percent spinoff of the Alcon eye care division are progressing with the Novartis board of directors providing final endorsement of the potential transaction. Novartis shareholders will vote on the proposed spin-off at Novartis' annual general meeting of shareholders on February 28, 2019.

March 22, 2019: Novartis (NVS) confirmed that certain important conditions precedent for the 100% spin-off of the Alcon eye care business have been met, including receipt of certain necessary authorizations and rulings. Completion of the transaction, by way of a distribution of a dividend in kind to Novartis shareholders and ADR holders, is expected to be on April 9, 2019.

April 9, 2019: Novartis (NVS) completed the spin-off of the Alcon eye care devices business through a dividend-in-kind distribution to holders of Novartis shares and ADRs (American Depositary Receipts), with each holder receiving 1 Alcon share for every 5 Novartis shares or ADRs held on April 8, 2019, at the close of business. Shares in Alcon, Inc. will be listed and commence trading today under the symbol "ALC" on the SIX Swiss Exchange (SIX) from 09:00 CET and on the New York Stock Exchange (NYSE) from 09:30 EST.

May 1, 2018: Ironwood Pharmaceuticals (IRWD), a commercial biotech company, announced that its Board of Directors has authorized an intent to separate into two independent, publicly traded companies (Ironwood and “R&D Co.”). The separation is expected to be completed in the first half of 2019 and is anticipated to be tax-free to Ironwood shareholders.

January 24, 2019: Ironwood Pharmaceuticals (IRWD) announced the composition of the Ironwood and Cyclerion Therapeutics, Inc. boards of directors, in connection with the previously announced planned business separation which is on track to be completed in the first half of 2019.

April 1, 2019: Ironwood Pharmaceuticals (IRWD) announced that it has completed the tax-free spin-off of its soluble guanylate cyclase (sGC) business, Cyclerion Therapeutics, Inc. (CYCN).

December 11, 2015: DuPont (DD) and The Dow Chemical Company (DOW) announced that their boards of directors unanimously approved a definitive agreement under which the companies will combine in an all-stock merger of equals. The combined company will be named DowDuPont. The parties intend to subsequently pursue a separation of DowDuPont into three independent, publicly traded companies through tax-free spin-offs. This would occur as soon as feasible, which is expected to be 18-24 months following the closing of the merger, subject to regulatory and board approval.

August 4, 2017: DuPont (DD) and The Dow Chemical Company (DOW) announced that all required regulatory approvals and clearances have been received, that all conditions to closing of their merger of equals have been satisfied, and that their merger of equals will close after the market closes on August 31, 2017. Shares of Dow and DuPont will cease trading at the close of the New York Stock Exchange on August 31. Shares of DowDuPont will begin trading on the NYSE under the stock ticker symbol “DWDP” on September 1, 2017. The companies continue to expect the intended spin-offs to occur within 18 months of closing.

September 1, 2017: DowDuPont (DWDP) announced the successful completion of the merger of equals between The Dow Chemical Company and E.I. du Pont de Nemours & Company (“DuPont”), effective Aug. 31, 2017. The combined entity is operating as a holding company under the name “DowDuPont™” with three divisions – Agriculture, Materials Science and Specialty Products.

September 12, 2017: DowDuPont (DWDP) announced that its Board of Directors and management, with the assistance of independent advisors, have completed their comprehensive review of the portfolio composition of the three intended independent companies. Following the portfolio realignments, the three intended companies of DowDuPont are as follows:
1) A leading Agriculture Company
2) A leading Materials Science Company
3) A leading Specialty Products Company

On a forecasted 2017 basis, the businesses that will be realigned to the Specialty Products Division account for total net sales of more than $8 billion and operating EBITDA of approximately $2.4 billion, including approximately 40 percent of the heritage Dow Corning EBITDA. Relative to the original merger agreement, the adjustments are as follows:

- Approximately $4 billion of net sales from the heritage Dow portfolio, evenly split between the Consumer Solutions and Infrastructure Solutions segments; and

- Approximately $4 billion of net sales from the heritage DuPont Performance Polymers business moving to the Specialty Products Division.

October 26, 2017: DowDuPont (DWDP) filed a  Form 8-K reflecting the new segment structure of DowDuPont. Following the Merger, new reportable segments were created and DowDuPont began to manage and report its operating results through the new reportable segments: Agriculture; Performance Materials & Coatings; Industrial Intermediates & Infrastructure; Packaging & Specialty Plastics; Electronics & Imaging; Nutrition & Biosciences; Transportation & Advanced Polymers; Safety & Construction and Corporate. DowDuPont will report geographic information for the following areas: U.S. & Canada, Asia Pacific, Latin America and Europe, Middle East, and Africa ("EMEA"). As a result of the Merger, Dow changed the geographic alignment for the country of India to be reflected in Asia Pacific (previously reported in EMEA) and aligned Puerto Rico to U.S. & Canada (previously reported in Latin America).

February 26, 2018: DowDuPont (DWDP) unveiled the brand names it plans to give the three independent companies it will create following the merger of the former DuPont and Dow Chemical. The company said the agriculture division will be named Corteva Agriscience, the materials science division will be called Dow and the specialty products division will be called DuPont. The materials science division is expected to be spun off by the end of the first quarter of 2019, while agriculture and specialty products are expected to separate by June 1, 2019.

March 8, 2019: DowDuPont (DWDP) said its board has approved the separation of its materials science division, paving the way for the creation of the new Dow. Dow will be an independent, publicly traded company that will list on the New York Stock Exchange on or about March 20 under the ticker symbol "DOW WI" on a when-issued basis and then begin regular-way trading April 2 under the ticker symbol "DOW."

April 1, 2019: DowDuPont (DWDP) announced that it has completed the separation of its Materials Science Division through the spin-off of Dow Inc.. Dow will begin “regular way” trading on the NYSE under the symbol “DOW”.

December 14, 2017: The Walt Disney Company (DIS) and Twenty-First Century Fox (FOX) announced that they have entered into a definitive agreement for Disney to acquire 21st Century Fox, including the Twentieth Century Fox Film and Television studios, along with cable and international TV businesses, for approximately $52.4 billion in stock. Immediately prior to the acquisition, 21st Century Fox will separate the Fox Broadcasting network and stations, Fox News Channel, Fox Business Network, FS1, FS2 and Big Ten Network into a newly listed company that will be spun off to its shareholders.

March 19, 2019: Twenty-First Century Fox (TFCF) announced that it has completed the distribution of all issued and outstanding shares of Fox Corporation (FOXA) common stock to 21CF stockholders on a pro rata basis. 21CF and FOX are now each a standalone, publicly traded company.

August 2, 2017: FMC Corporation (FMC) announced in their Quarterly Report, filed on August 2, 2017 that they continue to invest in FMC Lithium and to move forward with their plans to expand their lithium hydroxide operations. They will continue to operate FMC Lithium as a standalone business within FMC. Their strategic intent is that they will spin off FMC Lithium as a separate, publicly traded company.

February 26, 2018: FMC Corp (FMC) is planning a $500 million initial public offering of a stake in its lithium business on the New York Stock Exchange this fall.

February 11, 2019: FMC Corporation (FMC) announced that its Board of Directors has approved the distribution of all of its remaining interest in Livent Corporation (LTHM) to FMC stockholders, payable on March 1, 2019, to shareholders of record as of 5:00 p.m. EST on February 25, 2019.

March 1, 2019: FMC Corporation (FMC) announced that it has completed the previously announced distribution of 123,000,000 shares of common stock of Livent Corporation (LTHM).

May 21, 2018: Wabtec Corporation (WAB) entered into a definitive agreement to combine with GE Transportation, a unit of General Electric Company (GE). GE Transportation will be combined in a transaction in which GE will (i) sell a portion of the assets of GE Transportation to Wabtec; (ii) complete the spin-off or split-off of a portion of GE Transportation to GE shareholders; and (iii) immediately thereafter merge GE Transportation with a wholly owned subsidiary of Wabtec. The transaction is expected to close in early 2019, subject to customary closing conditions, approval by Wabtec shareholders, and regulatory approvals.

January 25, 2019: Wabtec Corporation (WAB) and GE (GE) announced that they have modified the terms of their merger agreement. Under the terms of the modified arrangements, which have been approved by Wabtec’s Board and by the Finance and Capital Allocation Committee of the GE Board, GE will complete the spin off of a portion of GE Transportation to GE shareholders and immediately thereafter merge GE Transportation into a wholly owned subsidiary of Wabtec. Upon closing, Wabtec shareholders will own approximately 50.8% of Wabtec on a fully diluted basis, compared to approximately 49.9% under the previous terms.

February 4, 2019: General Electric (GE) said that it expects to close the merger of its transportation business with Wabtec Corp (WAB) on February 25 and set a record date for distribution of shares.